• Issues related to health care workforce shortages. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
• Issues concerning access to and reimbursement for the Medicare Hospice benefit. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The Hospice Special Focus Program. S. 1845, Expanding Access to Palliative Care Act and issues related to community-based palliative care. Issues concerning hospice surveys. H.R.2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024, H.R.4366, Consolidated Appropriations Act, 2024, and H.R.2882, Further Consolidated Appropriations Act, 2024, as they relate to hospice reimbursement.

Duration: June 26, 2008 to September 15, 2015

General Issues: Health Issues, Medicare/Medicaid

Spending: about $5,570,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), White House Office, Office of Management & Budget (OMB), Executive Office of the President (EOP), Medicare Payment Advisory Commission (MedPAC), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)